-+ 0.00%
-+ 0.00%
-+ 0.00%
Aptevo names Mary Janatpour chief scientific officer
Share
Listen to the news
Aptevo names Mary Janatpour chief scientific officer
  • Aptevo named Mary J. Janatpour as senior vice president, chief scientific officer in its second-quarter 2026 update.
  • Janatpour brings more than 25 years of oncology R&D leadership across large biopharma groups and emerging biotech companies.
  • She will lead research and preclinical development, supporting clinical priorities, the multispecific pipeline, radiopharmaceutical collaboration, and trispecific solid-tumor programs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608140805ACCESSWRNAPR_____1207149) on August 14, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending